Literature DB >> 19179664

Searching for miR-acles in cardiac fibrosis.

Eva van Rooij, Eric N Olson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19179664      PMCID： PMC2747251          DOI： 10.1161/CIRCRESAHA.108.192492

Source DB:  PubMed          Journal:  Circ Res        ISSN： 0009-7330            Impact factor:   17.367


× No keyword cloud information.
  18 in total

Review 1.  Fibrosis in heart disease: understanding the role of transforming growth factor-beta in cardiomyopathy, valvular disease and arrhythmia.

Authors:  Razi Khan; Richard Sheppard
Journal:  Immunology       Date:  2006-05       Impact factor: 7.397

Review 2.  The functions of animal microRNAs.

Authors:  Victor Ambros
Journal:  Nature       Date:  2004-09-16       Impact factor: 49.962

3.  microRNA-133a regulates cardiomyocyte proliferation and suppresses smooth muscle gene expression in the heart.

Authors:  Ning Liu; Svetlana Bezprozvannaya; Andrew H Williams; Xiaoxia Qi; James A Richardson; Rhonda Bassel-Duby; Eric N Olson
Journal:  Genes Dev       Date:  2008-11-17       Impact factor: 11.361

4.  A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure.

Authors:  Eva van Rooij; Lillian B Sutherland; Ning Liu; Andrew H Williams; John McAnally; Robert D Gerard; James A Richardson; Eric N Olson
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-15       Impact factor: 11.205

Review 5.  The emerging role of microRNAs in cardiac remodeling and heart failure.

Authors:  Vijay Divakaran; Douglas L Mann
Journal:  Circ Res       Date:  2008-11-07       Impact factor: 17.367

Review 6.  Connective tissue growth factor and cardiac fibrosis.

Authors:  A Daniels; M van Bilsen; R Goldschmeding; G J van der Vusse; F A van Nieuwenhoven
Journal:  Acta Physiol (Oxf)       Date:  2008-11-15       Impact factor: 6.311

7.  MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts.

Authors:  Thomas Thum; Carina Gross; Jan Fiedler; Thomas Fischer; Stephan Kissler; Markus Bussen; Paolo Galuppo; Steffen Just; Wolfgang Rottbauer; Stefan Frantz; Mirco Castoldi; Jürgen Soutschek; Victor Koteliansky; Andreas Rosenwald; M Albert Basson; Jonathan D Licht; John T R Pena; Sara H Rouhanifard; Martina U Muckenthaler; Thomas Tuschl; Gail R Martin; Johann Bauersachs; Stefan Engelhardt
Journal:  Nature       Date:  2008-11-30       Impact factor: 49.962

8.  miR-133 and miR-30 regulate connective tissue growth factor: implications for a role of microRNAs in myocardial matrix remodeling.

Authors:  Rudy F Duisters; Anke J Tijsen; Blanche Schroen; Joost J Leenders; Viola Lentink; Ingeborg van der Made; Veronica Herias; Rick E van Leeuwen; Mark W Schellings; Paul Barenbrug; Jos G Maessen; Stephane Heymans; Yigal M Pinto; Esther E Creemers
Journal:  Circ Res       Date:  2008-12-18       Impact factor: 17.367

Review 9.  Toward microRNA-based therapeutics for heart disease: the sense in antisense.

Authors:  Eva van Rooij; William S Marshall; Eric N Olson
Journal:  Circ Res       Date:  2008-10-24       Impact factor: 17.367

10.  Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis.

Authors:  Eva van Rooij; Lillian B Sutherland; Jeffrey E Thatcher; J Michael DiMaio; R Haris Naseem; William S Marshall; Joseph A Hill; Eric N Olson
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-22       Impact factor: 11.205
View more
  34 in total

Review 1.  Exosomes Generated From iPSC-Derivatives: New Direction for Stem Cell Therapy in Human Heart Diseases.

Authors:  Ji-Hye Jung; Xuebin Fu; Phillip C Yang
Journal:  Circ Res       Date:  2017-01-20       Impact factor: 17.367

2.  Relations between circulating microRNAs and atrial fibrillation: data from the Framingham Offspring Study.

Authors:  David D McManus; Honghuang Lin; Kahraman Tanriverdi; Michael Quercio; Xiaoyan Yin; Martin G Larson; Patrick T Ellinor; Daniel Levy; Jane E Freedman; Emelia J Benjamin
Journal:  Heart Rhythm       Date:  2014-01-18       Impact factor: 6.343

3.  Cellular Communications in the Heart.

Authors:  Katerina Fountoulaki; Nikolaos Dagres; Efstathios K Iliodromitis
Journal:  Card Fail Rev       Date:  2015-10

4.  Early and Short-term Triiodothyronine Supplementation Prevents Adverse Postischemic Cardiac Remodeling: Role of Transforming Growth Factor-β1 and Antifibrotic miRNA Signaling.

Authors:  Giuseppina Nicolini; Francesca Forini; Claudia Kusmic; Letizia Pitto; Laura Mariani; Giorgio Iervasi
Journal:  Mol Med       Date:  2015-11-23       Impact factor: 6.354

5.  Circulating MicroRNAs in cardiovascular disease.

Authors:  David D McManus; Victor Ambros
Journal:  Circulation       Date:  2011-11-01       Impact factor: 29.690

6.  MicroRNA-29c is a signature microRNA under high glucose conditions that targets Sprouty homolog 1, and its in vivo knockdown prevents progression of diabetic nephropathy.

Authors:  Jianyin Long; Yin Wang; Wenjian Wang; Benny H J Chang; Farhad R Danesh
Journal:  J Biol Chem       Date:  2011-02-10       Impact factor: 5.157

Review 7.  MicroRNAs--regulators of signaling networks in dilated cardiomyopathy.

Authors:  Sathyamangla V Naga Prasad; Sadashiva S Karnik
Journal:  J Cardiovasc Transl Res       Date:  2010-05-01       Impact factor: 4.132

Review 8.  Cardiac-targeted delivery of regulatory RNA molecules and genes for the treatment of heart failure.

Authors:  Wolfgang Poller; Roger Hajjar; Heinz-Peter Schultheiss; Henry Fechner
Journal:  Cardiovasc Res       Date:  2010-02-22       Impact factor: 10.787

Review 9.  Membrane-associated matrix proteolysis and heart failure.

Authors:  Francis G Spinale; Joseph S Janicki; Michael R Zile
Journal:  Circ Res       Date:  2013-01-04       Impact factor: 17.367

Review 10.  Targeting the TGFβ signalling pathway in disease.

Authors:  Rosemary J Akhurst; Akiko Hata
Journal:  Nat Rev Drug Discov       Date:  2012-09-24       Impact factor: 84.694
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.